> R&D > Publication
[pH-감응 B7H3 ADC] 2025년 AACR 발표 포스터
A next generation ADC : AR153, pH-dependent anti-B7-H3-MMAE
[TGF-b SelecTrap] 2024년 SITC 발표 포스터
[HLA-G ALiCE] 2024년 SITC 발표 포스터
AR092, a proprietary HLA-G/CD3 T cell engager,
induces anti-tumor activity and minimal toxicity in solid tumors
[CD39 항체] 2024년 AACR 발표 포스터
Discovery and Evaluation of AR062, anti-CD39 mAb for the treatment of cancer
[YBL-006 임상 결과] 2023년 SITC 발표 포스터
Safety and Efficacy of YBL-006, a Novel Anti PD 1 Antibody, in Advanced
Solid Tumors Including G3 NET/NEC: Results From a Phase 1/2a Study
[YBL-006 임상 중간결과 포스터] 2021년 ESMO 발표 포스터
Interim results of phase 1 dose escalation study of YBL-006,
a novel anti-PD-1 monoclonal antibody in advanced solid tumors
[PD-L1 ALiCE] Biomaterials 271 (2021) 120760 발표 논문
Development of an antibody-like T-cell engager based on VH-VL
heterodimer formation and its application in cancer therapy
[YBL-006 전임상 결과] 2020년 AACR 발표 포스터
Preclinical Characterization of YBL-006,
a Fully Human Anti-PD-1 Antibody Being Ready for Clinical Studies
[PD-L1 ALiCE] 2018년 Protein Engineering Summit 발표 포스터
The making of Antibody Like (T) Cell Engager on the basis of VH-VL
heterodimer formation and its application in cancer therapy
[PD-L1 ALiCE] 2018년 BsAB Congress 발표 포스터
The making of Antibody Like (T) Cell Engager on the basis of VH-VL
heterodimer formation and its application in cancer therapy
[B7H3 항체] 2018년 Protein Engineering Summit 발표 포스터
Screening and Characterization of B7-H3-specific human antibody